Merck & Co., Inc. Intangible Assets, Net (Excluding Goodwill)
Merck & Co., Inc. (MRK) had Intangible Assets, Net (Excluding Goodwill) of $24.98 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-08-07
- 2026-06-30: Intangible Assets, Net (Excluding Goodwill) $24.98B.
- 2026-03-31: Intangible Assets, Net (Excluding Goodwill) $25.75B.
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $26.68B.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $15.31B.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $24.98B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $25.75B 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $26.68B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $15.31B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $15.19B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $15.76B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $16.37B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $17.01B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $16.98B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $17.57B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $18.01B 10-K · filed 2025-02-25 | |
| 2023-09-30 | $19.20B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $19.66B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $19.86B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $20.27B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $21.37B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $22.50B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $23.02B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $22.93B 10-K · filed 2023-02-24 | |
| 2021-09-30 | $13.38B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $13.62B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $14.40B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $14.10B 10-K · filed 2022-02-25 | $14.60B 10-K · filed 2021-02-25 |
| 2020-09-30 | $16.68B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $16.57B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $16.10B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $14.20B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $12.31B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $13.38B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $11.00B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $13.10B 10-K · filed 2020-02-26 | $11.43B 10-K · filed 2019-02-27 |
| 2018-09-30 | $12.18B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $12.90B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $13.50B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $14.18B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $15.14B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $16.12B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $16.86B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $17.30B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $20.51B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $20.32B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $21.36B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $22.60B 10-K · filed 2017-02-28 | |
| 2015-09-30 | $23.72B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $24.75B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $26.08B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $20.39B 10-K · filed 2016-02-26 | |
| 2014-09-30 | $20.39B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $18.83B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $20.52B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $23.80B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $25.00B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $26.33B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $28.11B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $29.08B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $30.32B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $31.62B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $33.00B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $34.30B 10-K · filed 2013-02-28 | |
| 2011-09-30 | $35.82B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $37.06B 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $37.91B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $39.46B 10-K · filed 2012-02-28 | |
| 2010-09-30 | $42.95B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $43.28B 10-Q · filed 2010-08-06 | |
| 2010-03-31 | $45.57B 10-Q · filed 2010-05-07 | |
| 2009-12-31 | $47.76B 10-K · filed 2011-02-28 | $47.66B 10-K · filed 2010-03-01 |
| 2008-12-31 | $525.40M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |